| Author |
Title |
JournalName |
Year D |
| Click on Column Headers to Re-Sort The Current List |
| Ziporyn T |
A growing industry and menace: makeshift laboratory's designer drugs |
JAMA |
1986 |
| Beck J, Morgan PA |
Designer drug confusion: a focus on MDMA |
J Drug Educ |
1986 |
| Climko RP, Roehrich H, Sw... |
Ecstacy: a review of MDMA and MDA |
Int J Psychiatry Med |
1986 |
| Stone DM, Stahl DC, Hanso... |
The effects of 3,4-methylenedioxymethamphetamine (MDMA) and 3,4-methyl... |
Eur J Pharmacol |
1986 |
| Gibb JW, Stone DM, Stahl ... |
The effects of amphetamine-like designer drugs on monoaminergic system... |
NIDA Res Monogr |
1987 |
| Bost RO |
3,4-Methylenedioxymethamphetamine (MDMA) and other amphetamine derivat... |
J Forensic Sci |
1988 |
| Buchanan JF, Brown CR |
'Designer drugs'. A problem in clinical toxicology |
Med Toxicol Adverse ... |
1988 |
| Callahan PM, Appel JB |
Differences in the stimulus properties of 3,4-methylenedioxyamphetamin... |
J Pharmacol Exp Ther |
1988 |
| Stanford MW |
Designer drugs: Medical aspects and clinical management |
Alcoholism Treatment... |
1988 |
| Schechter MD |
Serotonergic-dopaminergic mediation of 3,4-methylenedioxymethamphetami... |
Pharmacol Biochem Be... |
1989 |
| Beebe DK, Walley E |
Update on street drugs in Mississippi |
J Miss State Med Ass... |
1989 |
| Gold LH, Geyer MA, Koob G... |
Neurochemical mechanisms involved in behavioral effects of amphetamine... |
NIDA Res Monogr |
1989 |
| Gibb JW, Stone DM, Johnso... |
Role of dopamine in the neurotoxicity induced by amphetamines and rela... |
NIDA Res Monogr |
1989 |
| Leikin JB, Krantz AJ, Zel... |
Clinical features and management of intoxication due to hallucinogenic... |
Med Toxicol Adverse ... |
1989 |
| De Souza EB, Battaglia G,... |
Neurotoxic effect of MDMA on brain serotonin neurons: evidence from ne... |
Ann N Y Acad Sci |
1990 |
| Kosten TR |
Neurobiology of abused drugs. Opioids and stimulants |
J Nerv Ment Dis |
1990 |
| Glennon RA |
Phenylalkylamine stimulants, hallucinogens, and designer drugs |
NIDA Res Monogr |
1991 |
| Ruttenber AJ |
Stalking the elusive designer drugs: Techniques for monitoring new pro... |
Journal of Addictive... |
1991 |
| Glennon RA |
Discriminative Stimulus Properties of Hallucinogens and Related Design... |
NIDA Res Mon |
1991 |
| Preston A |
Pointing out the Risk |
Nursing Times |
1992 |
| Sternbach GL, Varon J |
'Designer drugs'. Recognizing and managing their toxic effects |
Postgrad Med |
1992 |
| Thurman EM, Pedersen MJ, ... |
Distinguishing sympathomimetic amines from amphetamine and methampheta... |
J Anal Toxicol |
1992 |
| Emerson TS, Cisek JE |
Methcathinone: a Russian designer amphetamine infiltrates the rural mi... |
Ann Emerg Med |
1993 |
| Bronson ME, Jiang W, Clar... |
Effects of Designer Drugs on the Chicken Embryo and 1-Day-Old Chicken |
Brain Res Bull |
1994 |
| House RV, Thomas PT, Bhar... |
Selective modulation of immune function resulting from in vitro exposu... |
Toxicology |
1995 |
| Bronson ME, Wages TD, Bed... |
Morphine, MDMA, MDA, and nexus produce a conditioned place preference ... |
Exp Clin Psychopharm... |
1996 |
| Maurer HH |
On the metabolism and the toxicological analysis of methylenedioxyphen... |
Ther Drug Monit |
1996 |
| Ensslin HK, Kovar KA, Mau... |
Toxicological detection of the designer drug 3,4-methylenedioxyethylam... |
J Chromatogr B Biome... |
1996 |
| Schwartz RH, Miller NS |
MDMA (ecstasy) and the rave: a review |
Pediatrics |
1997 |
| Glennon RA, Young R, Duka... |
Initial characterization of PMMA as a discriminative stimulus |
Pharmacol Biochem Be... |
1997 |
| Kua EH |
Designer Drugs--the Ecstasy and the Agony |
Singapore Med J |
1997 |
| Tsatsakis AM, Michalodimi... |
MDEA related death in Crete: a case report and literature review |
Vet Hum Toxicol |
1997 |
| Dal Cason TA |
The characterization of some 3,4-methylenedioxycathinone MDCATH homolo... |
Forensic Science Int... |
1997 |
| Keller T, Miki A, Regensc... |
Detection of designer drugs in human hair by ion mobility spectrometry... |
Forensic Sci Int |
1998 |
| Byard RW, Gilbert J, Jame... |
Amphetamine derivative fatalities in South Australia--is 'Ecstasy' the... |
Am J Forensic Med Pa... |
1998 |
| Plessinger MA |
Prenatal exposure to amphetamines. Risks and adverse outcomes in pregn... |
Obstet Gynecol Clin ... |
1998 |
| Young R, Glennon RA |
Discriminative stimulus properties of (-)ephedrine |
Pharmacol Biochem Be... |
1998 |
| Wollina U, Kammler HJ, He... |
Ecstasy pimples - a new facial dermatosis |
Dermatology |
1998 |
| Schwab M, Seyringer E, Br... |
Fatal MDMA intoxication |
Lancet |
1999 |
| Ramseier A, Caslavska J, ... |
Stereoselective screening for and confirmation of urinary enantiomers ... |
Electrophoresis |
1999 |
| Rochester JA, Kirchner JT |
Ecstasy (3,4-methylenedioxymethamphetamine): history, neurochemistry, ... |
J Am Board Fam Pract |
1999 |
| Appel JB, West WB, Roland... |
Increasing the selectivity of drug discrimination procedures |
Pharmacol Biochem Be... |
1999 |
| Young R, Dukat M, Malmusi... |
Stimulus properties of PMMA: effect of optical isomers and conformatio... |
Pharmacol Biochem Be... |
1999 |
| Glennon RA |
Arylalkylamine drugs of abuse: an overview of drug discrimination stud... |
Pharmacol Biochem Be... |
1999 |
| Kreth KP,Kovar KA, Schwab... |
Identification of the Human Cytochromes P450 Involved in the Oxidative... |
Biochem Pharmacol |
2000 |
| Maurer HH, Bickeboeller-F... |
Toxicokinetics and analytical toxicology of amphetamine-derived design... |
Toxicol Lett |
2000 |
| Bogusz MJ, Kruger KD, Mai... |
Analysis of underivatized amphetamines and related phenethylamines wit... |
J Anal Toxicol |
2000 |
| Christophersen AS |
Amphetamine designer drugs - an overview and epidemiology |
Toxicol Lett |
2000 |
| Morland J |
Toxicity of drug abuse--amphetamine designer drugs (ecstasy): mental e... |
Toxicol Lett |
2000 |
| Ramseier A, Siethoff C, C... |
Confirmation testing of amphetamines and designer drugs in human urine... |
Electrophoresis |
2000 |
| Clauwaert KM, Van Bocxlae... |
Determination of the designer drugs 3, 4-methylenedioxymethamphetamine... |
Clin Chem |
2000 |
| Gomez-Balaguer M, Pena H,... |
Syndrome of Inappropriate Antidiuretic Hormone Secretion and 'Designer... |
Journal of Pediatric... |
2000 |
| Pepin G, Cheze M, Billaul... |
New hallucinogenic in Europe: Ayahuasca or the Vine of the Spirit |
Journal of Forensic ... |
2000 |
| Borth S, Hänsel W, Rösner... |
Synthesis of 2,3- and 3,4-methylenedioxyphenylalkylamines and their re... |
Forensic Sci Int |
2000 |
| Clauwaert KM, Van Bocxlae... |
Determination of the designer drugs 3, 4-methylenedioxymethamphetamine... |
Clin Chem |
2000 |
| Anderson C |
Water intake probed in death |
Boulder Daily Camera |
2001 |
| Zhao H, Brenneisen R, Sch... |
Profiles of urine samples taken from Ecstasy users at Rave parties: an... |
J Anal Toxicol |
2001 |
| De Letter EA, Coopman VA,... |
One fatal and seven non-fatal cases of 4-methylthioamphetamine 4-MTA i... |
Int J Legal Med |
2001 |
| de Boer D, Bosman IJ, Hid... |
Piperazine-like compounds: a new group of designer drugs-of-abuse on t... |
Forensic Sci Int |
2001 |
| Clauwaert KM, Van Bocxlae... |
Stability study of the designer drugs 'MDA, MDMA and MDEA' in water, s... |
Forensic Sci Int |
2001 |
| Kraemer T, Maurer HH |
Toxicokinetics of amphetamines: metabolism and toxicokinetic data of d... |
Ther Drug Monit |
2002 |
| von Sydow K, Lieb R, Pfis... |
Use, abuse and dependence of ecstasy and related drugs in adolescents ... |
Drug and Alcohol Dep... |
2002 |
| Glennon RA, Young R, Rang... |
Further characterization of the stimulus properties of 5,6,7,8- tetrah... |
Pharmacol Biochem Be... |
2002 |
| Pellegrini M, Rosati F, P... |
Rapid screening method for determination of Ecstasy and amphetamines i... |
J Chromatogr B Analy... |
2002 |
| Wax PM |
Just a Click Away: Recreational Drug Web Sites on the Internet |
Pediatrics |
2002 |
| Meyer A, Mayerhofer A, Ko... |
Enantioselective metabolism of the designer drugs 3,4-methylenedioxyme... |
Neurosci Lett |
2002 |
| Simonsen KW, Kaa E, Niels... |
Narcotics at street level in Denmark. A prospective investigation from... |
Forensic Sci Int |
2003 |
| De Letter EA, Espeel MF, ... |
Immunohistochemical demonstration of the amphetamine derivatives 3,4-m... |
Int J Legal Med |
2003 |
| Peters FT, Schaefer S, St... |
Screening for and validated quantification of amphetamines and of amph... |
J Mass Spectrom |
2003 |
| Dams R, De Letter EA, Mor... |
Fatality due to combined use of the designer drugs MDMA and PMA: a dis... |
J Anal Toxicol |
2003 |
| Turner C, Russell A, Brow... |
Prevalence of illicit drug use in young Australian women, patterns of ... |
Addiction |
2003 |
| Carvalho M, Milhazes N, R... |
Hepatotoxicity of 3,4-methylenedioxyamphetamine and alpha-methyldopami... |
Arch Toxicol |
2003 |
| Maurer HH, Kraemer T, Spr... |
Chemistry, pharmacology, toxicology, and hepatic metabolism of designe... |
Ther Drug Monit |
2004 |
| de la Torre R, Farre; M, ... |
Clinical pharmacokinetics of amfetamine [amphetamine] and related subs... |
Clin Pharmacokinet |
2004 |
| Boatto G, Nieddu M, Carta... |
Determination of amphetamine-derived designer drugs in human urine by ... |
J Chromatogr B Analy... |
2005 |
| Fantegrossi WE, Winger G,... |
Reinforcing and discriminative stimulus effects of 1-benzylpiperazine ... |
Drug Alcohol Depend |
2005 |
| Staack RF, Maurer HH |
Metabolism of designer drugs of abuse |
Curr Drug Metab |
2005 |
| Casteele SR, Bouche MP, V... |
LC-MS/MS in the elucidation of an isomer of the recreational drug meth... |
J Sep Sci |
2005 |
| Balíková M |
Nonfatal and fatal DOB (2,5-dimethoxy-4-bromoamphetamine) overdose |
Forensic Sci Int |
2005 |
| Schifano F, Deluca P, Ago... |
New trends in the cyber and street market of recreational drugs? The c... |
J Psychopharmacol |
2005 |
| Schifano F, Deluca P, Ago... |
New trends in the cyber and street market of recreational drugs? The c... |
J Psychopharmacol |
2005 |
| Bossong MG, Van Dijk JP, ... |
Methylone and mCPP, two new drugs of abuse? |
Addict Biol |
2005 |
| Ewald AH, Fritschi G, Bor... |
Designer drugs 2,5-dimethoxy-4-bromo-amphetamine DOB and 2,5-dimethoxy... |
J Mass Spectrom |
2006 |
| Theobald DS, Maurer HH |
Identification of monoamine oxidase and cytochrome P450 isoenzymes inv... |
Biochem Pharmacol |
2007 |
| Itokawa M, Iwata K, Takah... |
Acute confusional state after designer tryptamine abuse |
Psychiatry Clin Neur... |
2007 |
| Pichini S, Pujadas M, Mar... |
Liquid chromatography-atmospheric pressure ionization electrospray mas... |
J Pharm Biomed Anal |
2008 |
| Uchiyama N, Kikura-Hanaji... |
[Analysis of designer drugs detected in the products purchased in fisc... |
Yakugaku Zasshi |
2008 |
| Nakagawa Y, Suzuki T, Tay... |
Cytotoxic effects of 3,4-methylenedioxy-N-alkylamphetamines, MDMA and ... |
Arch Toxicol |
2009 |
| Westphal F, Junge T, Girr... |
Structure elucidation of a new designer benzylpiperazine: 4-bromo-2,5-... |
Forensic Sci Int |
2009 |
| Auwärter V, Dresen S, Wei... |
'Spice' and other herbal blends: harmless incense or cannabinoid desig... |
Journal of Mass Spec... |
2009 |
| Mustata C, Torrens M, Par... |
[Spice drugs: cannabinoids as a new designer drugs] |
Adicciones |
2009 |
| Zaitsu K, Katagi M, Kamat... |
Determination of the metabolites of the new designer drugs bk-MBDB and... |
Forensic Sci Int |
2009 |
| Lindigkeit R, Boehme A, E... |
Spice: a never ending story? |
Forensic Sci Int |
2009 |
| Drees JC, Stone JA, Wu AH |
Morbidity involving the hallucinogenic designer amines MDA and 2C-I |
J Forensic Sci |
2009 |
| Uchiyama N, Miyazawa N, K... |
[Analysis of newly distributed designer drugs detected in the products... |
Yakugaku Zasshi |
2010 |
| Uchiyama N, Kikura-Hanaji... |
Chemical analysis of synthetic cannabinoids as designer drugs in herba... |
Forensic Sci Int |
2010 |
| Meyer MR, Wilhelm J, Pete... |
Beta-keto amphetamines: studies on the metabolism of the designer drug... |
Anal Bioanal Chem |
2010 |
| Lindigkeit R, Böhme A, Ei... |
Synthese, Charakterisierung und Analyse von JWH-018-StrukturanalogenSy... |
|
2010 |
| Wohlfarth A, Weinmann W |
Bioanalysis of new designer drugs |
|
2010 |
| Meyer MR, Maurer HH |
Metabolism of designer drugs of abuse: an updated review |
Curr Drug Metab |
2010 |
